2004
DOI: 10.1111/j.1443-1661.2004.00454.x
|View full text |Cite
|
Sign up to set email alerts
|

Eus Guided Fna for Mediastinal Tumors (Lung Cancer and Lymph Nodes)

Abstract: Trans-esophageal endoscopic ultrasound-guided fine needle aspiration biopsy (EUS-FNA) has proven to be a safe and minimally invasive tissue-sampling method which can be used to obtain a cytological diagnosis from mediastinal lesions. The aims of EUS-FNA in the mediastinum are either to diagnose a lesion of unknown origin, to stage mediastinal lymph nodes in lung cancer patients or to diagnose other diseases involving lymph nodes of the mediastinum. In patients with non-small cell lung cancer (NSCLC), surgery m… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
5
1

Year Published

2005
2005
2022
2022

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 8 publications
(6 citation statements)
references
References 59 publications
0
5
1
Order By: Relevance
“…The reported complication rate of EUS-FNA is ,0.5%, most of these were minor [2]. This is in contrast with the more invasive method of mediastinoscopy, with a reported complication rate of 2-5% and with the potential of fairly serious complications.…”
contrasting
confidence: 46%
See 1 more Smart Citation
“…The reported complication rate of EUS-FNA is ,0.5%, most of these were minor [2]. This is in contrast with the more invasive method of mediastinoscopy, with a reported complication rate of 2-5% and with the potential of fairly serious complications.…”
contrasting
confidence: 46%
“…In expert hands the sensitivity of endoscopic ultrasound-guided fine-needle aspiration biopsy (EUS-FNA) for these lesions reaches 90-98%. The number of patients included in the publications is currently .1,500 patients [2]. In this issue of European Respiratory Journal, CADDY et al [3] further underline the benefit of EUS-FNA in mediastinal staging of selected patients with NSCLC and for diagnosis of unexplained mediastinal lymph nodes.…”
mentioning
confidence: 99%
“…EBUS-TBNA has reported pooled sensitivity of roughly 90% for the staging of lung cancer [6,13]. These statistics are comparable to a pooled sensitivity of 89% for video mediastinoscopy, which is considered superior to that of conventional cervical mediastinoscopy [7,10].…”
Section: Mediastinal Lesionsmentioning
confidence: 96%
“…Many of the concerns regarding the use and adoption of C-TBNA were allayed with the introduction of EBUS-TBNA. The first report on the clinical application of linear probe EBUS was published in 2004 [6]. The literature from the ASTER trial in 2013 integrated the era of EBUS-TBNA in the staging and diagnostic algorithm of cancer in the lung and mediastinum [7].…”
Section: Mediastinal Lesionsmentioning
confidence: 99%
“…T he initial step in the evaluation of suspected intrathoracic (mediastinal and hilar) lymph node enlargement is contrast-enhanced computed tomography (CT) of the thorax [1]. Subsequently, a cytologic or histologic specimen from the intrathoracic lymph nodes can be obtained with various techniques such as CT-guided fine needle aspiration (FNA), conventional transbronchial needle aspiration (TBNA), endobronchial ultrasound (EBUS)-guided TBNA, endoscopic ultrasound (EUS)-guided FNA, EUS with an echobronchoscope, and mediastinoscopy [2][3][4][5][6][7][8][9]. EBUS-TBNA is the preferred minimally invasive technique for mediastinal lymph node sampling and cytologic diagnosis [9][10][11][12].…”
mentioning
confidence: 99%